Skip to content

A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female

A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03516266
Enrollment
7920
Registered
2018-05-04
Start date
2018-05-10
Completion date
2020-12-31
Last updated
2018-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Floor

Keywords

Pelvic floor muscle strength, Premenopausal nullipara, Childbirth, Postmenopausal

Brief summary

This study aims to investigate the status of pelvic floor function of healthy female in China, including premenopausal nullipara, premenopausal women with childbirth and postmenopausal women.

Detailed description

This is a cross-sectional survey. The normal physical examination population is divided into three groups,including premenopausal nullipara, premenopausal women with childbirth and postmenopausal women. The pelvic floor muscle function in three groups are evaluated. The modified Oxford Grading Scale and Levator ani testing is used to quantify PFM strength through vaginal palpation. Pelvic floor muscle strength ,endurance, repetition,vaginal contraction pressure and the knack test are evaluated using a PHENIX USB 8 neuromuscular stimulation therapy system (Company: Vivaltis-Electronic Concept Lignon Innovation, Montpellier, France). In six different regions of China according to geographic region (northwest, southwest, north, east, northeast, and central-south China) , 1 or more hospitals in each area are selected as sub-centers, which needs to complete the evaluation of pelvic floor muscle function of 360 cases in 3 groups totally.

Interventions

None listed

Sponsors

Liuzhou Maternity and Child Healthcare Hospital
CollaboratorOTHER
Qingdao Municipal Hospital
CollaboratorOTHER
Zhongshan People's Hospital, Guangdong, China
CollaboratorOTHER
The First Affiliated Hospital with Nanjing Medical University
CollaboratorOTHER
Second Affiliated Hospital of Soochow University
CollaboratorOTHER
Maternity and Child Health Hospital of Changsha
CollaboratorUNKNOWN
Henan Provincial People's Hospital
CollaboratorOTHER
Huaian Maternal and Child Health Care Hospital
CollaboratorOTHER
Hunan Provincial Maternal and Child Health Care Hospital
CollaboratorOTHER
The Fourth Hospital of Shijiazhuang
CollaboratorOTHER
Shenzhen Luohu District Maternity And Child Healthcare Hospital
CollaboratorUNKNOWN
Second Affiliated Hospital of Wenzhou Medical University
CollaboratorOTHER
Hubei Shiyan People's Hospital
CollaboratorUNKNOWN
Changzhi Maternity & Child Health Hospital
CollaboratorOTHER
Maternal and Child Health Care Hospital of Xinjiang Uygur Autonomous Region
CollaboratorUNKNOWN
The First Hospital of Hebei Medical University
CollaboratorOTHER
Shen-Zhen City Maternity and Child Healthcare Hospital
CollaboratorOTHER
Dalian Medical University
CollaboratorOTHER
Maternity and Child Care Center of QinHuangDao City
CollaboratorUNKNOWN
The People's Hospital of Leshan
CollaboratorOTHER
Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Group A:Premenopausal women without history of abortion or delivery 1. Having sex life and tolerable to vaginal examination 2. Premenopausal women without history of abortion over 16 weeks 3. Premenopausal women without history of childbirth 4. Planning to live locally for a long time Group B:Premenopausal women with childbirth 1. Having sex life and tolerable to vaginal examination 2. Premenopausal women with childbirth (including cesarean section or natural birth). 3. Planning to live locally for a long time Group C:Postmenopausal women (over a year, except surgical menopause) 1. Having sex life and tolerable to vaginal examination 2. Postmenopausal women 3. Planning to live locally for a long time

Exclusion criteria

1. Incontinence 4 weeks before enrollment 2. History of fecal incontinence 3. Prolapse beyond the level of the hymen 4. History of radical operation of pelvic cavity(cervical cancer,rectal cancer,bladder cancer, ect) 5. History of pelvic radiotherapy 6. History of pelvic floor surgery 7. History of abortion over 16 weeks' pregnancy or in 1 year after delivery 8. Duration of pregnancy 9. Duration of lactation 10. History of hysterectomy 11. Latex allergy 12. Colpitis

Design outcomes

Primary

MeasureTime frameDescription
maximum vaginal contraction pressure1 dayit is measured by manometry, range(80-150cmH2O). The higher values represent better outcomes.

Secondary

MeasureTime frameDescription
Pelvic floor muscle strength(repetition)1 dayLevator ani testing is used to quantify PFM strength. range(0-5). The higher values represent better outcomes.
Pelvic floor muscle contraction endurance1 daymuscle contractions maintained for 0 s are defined as grade 0, 1 s as grade I, 2 s as grade II, 3 s as grade III, 4 s as grade IV, and 5 s or longer as grade V. Normal muscles can maintain the contraction for 5 s. range(0-5s). The higher values represent better outcomes.
Pelvic floor muscle strength1 dayThe modified Oxford Grading Scale is used to quantify PFM strength through vaginal palpation. range(0-5).The higher values represent better outcomes. through vaginal palpation.
the knack test1 daya voluntary PFM contraction before or during coughing. That the contraction could be performed represents normal.
vaginal rest pressure1 daymeasure when no vaginal contraction by manometry. range(25-50 cmH2O). the lower and the higher values represent abnormal outcomes.
pelvic organ prolapse quantification1 dayPOP-Q is measured when maximum valsalva. range(0-4). stage 0 represents normal.

Countries

China

Contacts

Primary ContactZhijing Sun, MD
sunzhj2001@sina.com13651314354
Backup ContactLan Zhu, MD
zhu_julie@vip.sina.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026